Status:
ACTIVE_NOT_RECRUITING
Evaluation of Health and Lifestyle Tool
Lead Sponsor:
Region Skane
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
35+ years
Brief Summary
The overall aim of the study is to observe the natural pattern of usage and metabolic outcomes in patients with type 2 diabetes who had access to the new digital tool as a stand-alone support in addit...
Detailed Description
Considerable evidence suggest that lifestyle changes can prevent or delay the onset of type 2 diabetes, and self-care behaviors largely determine HbA1c. Modifiable lifestyle factors have been establis...
Eligibility Criteria
Inclusion
- Patients with type 2 diabetes at or above 35 years of age
- HbA1C at 52 mmol/mol or above
- Diagnosis of diabetes mellitus was based on prior documentation or treatment with anti-hyperglycemic medication
- written informed consent.
Exclusion
- type 1 diabetes, MODY or secondary diabetes
- conditions or treatments that in the judgement of the Investigator could affect the study evaluation
- connection with the study team, funders, authorities, universities or other public or private bodies in such a way that specific interests in the study outcomes could be suspected.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04691973
Start Date
January 1 2017
End Date
December 31 2026
Last Update
July 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Center
Malmo, Sweden, 20502